4.5316

7.88% 0.3416

Cardlytics Inc (CDLX)

Overview News Price History Option Chain Financials Why CDLX Down? Discussions Forecast

Cardlytics Inc stock is traded at $4.5316, with a volume of 608.72K. It is up +7.88% in the last 24 hours and up +37.39% over the past month. Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

Previous Close:

$4.19

Open:

$4.25

24h Volume:

608.72K

Relative Volume:

0.52

Market Cap:

$214.81M

Revenue:

$312.80M

Net Income/Loss:

$-115.27M

P/E Ratio:

-0.4161

EPS:

-10.89

Net Cash Flow:

$-12.58M

1W Performance:

+13.28%

1M Performance:

+37.39%

6M Performance:

-69.62%

1Y Performance:

-67.41%

1-Day Range:

$4.19

$4.62

1-Week Range:

$3.98

$4.62

52-Week Range:

$2.8901

$20.52

Cardlytics Inc Stock (CDLX) Company Profile

Name

Cardlytics Inc

Sector

Communication Services (261)

Industry

Advertising Agencies (40)

Phone

888-798-5802

Address

675 PONCE DE LEON AVENUE, NE, ATLANTA, GA

Employee

457

Twitter

@cardlytics

Next Earnings Date

2024-11-06

Latest SEC Filings

CDLX's Discussions on Twitter

Cardlytics Inc Stock (CDLX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-08-22	Downgrade	Wells Fargo	Equal Weight → Underweight
Jul-14-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Jul-13-22	Downgrade	BofA Securities	Neutral → Underperform
Jul-12-22	Downgrade	Craig Hallum	Buy → Hold
Apr-05-22	Resumed	Wells Fargo	Overweight
Jun-18-21	Initiated	Needham	Buy
Apr-15-21	Upgrade	Wells Fargo	Equal Weight → Overweight
Apr-14-21	Upgrade	Craig Hallum	Hold → Buy
Mar-05-21	Upgrade	BofA Securities	Underperform → Neutral
Jan-14-21	Downgrade	William Blair	Outperform → Mkt Perform
Aug-28-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Apr-21-20	Downgrade	BofA/Merrill	Buy → Underperform
Mar-04-20	Downgrade	Craig Hallum	Buy → Hold
Jan-15-20	Downgrade	Raymond James	Outperform → Mkt Perform
Dec-02-19	Initiated	Craig Hallum	Buy
Nov-14-19	Downgrade	JP Morgan	Overweight → Neutral
Aug-09-19	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jul-24-19	Reiterated	BofA/Merrill	Buy
Jul-01-19	Initiated	William Blair	Outperform
Jan-15-19	Upgrade	BofA/Merrill	Neutral → Buy

View All

Cardlytics Inc Stock (CDLX) Latest News

08:20 AM

After Leaping 27% Cardlytics, Inc. (NASDAQ:CDLX) Shares Are Not Flying Under The Radar - Simply Wall St

08:20 AM

Nov 04, 2024

SG Americas Securities LLC Takes Position in Cardlytics, Inc. (NASDAQ:CDLX) - Defense World

Oct 30, 2024

Oct 25, 2024

Cardlytics CEO Amit Gupta sells shares worth $86,923 By Investing.com - Investing.com Australia

Oct 25, 2024

Brokerages Set Cardlytics, Inc. (NASDAQ:CDLX) Target Price at $6.92 - Defense World

Oct 25, 2024

Oct 24, 2024

Cardlytics CEO Amit Gupta sells shares worth $86,923 - Investing.com

Oct 24, 2024

Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells 22,607 Shares of Stock - MarketBeat

Oct 24, 2024

Oct 23, 2024

Cardlytics Announces Timing of Its Third Quarter 2024 Earnings Release - GlobeNewswire

Oct 23, 2024